How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States?

被引:0
|
作者
Ray M. Merrill
Kirk A. Dearden
机构
来源
Cancer Causes & Control | 2004年 / 15卷
关键词
cancer; incidence; mortality; Poisson regression; tobacco;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: Data from the 11s Surveillance, Epidemiology, and End Results tumor registries cover 14% of the US population and are often used to provide national estimates of cancer incidence and survival. Cancer mortality data for the US and for SEER are compared to assess the representation of SEER to the US.
引用
收藏
页码:1027 / 1034
页数:7
相关论文
共 50 条
  • [41] Malignant mesothelioma surveillance: A comparison of ICD 10 mortality data with SEER incidence data in nine areas of the United States
    Pinheiro, GA
    Antao, VCS
    Bang, KM
    Attfield, MD
    INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2004, 10 (03) : 251 - 255
  • [42] Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program
    Wang, Haosheng
    Chen, Xueliang
    Zhao, Jianwu
    Kang, Mingyang
    Dong, Rongpeng
    Wang, Kai
    Qu, Yang
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [43] Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute
    Derek R. Johnson
    Paul D. Brown
    Evanthia Galanis
    Julie E. Hammack
    Journal of Neuro-Oncology, 2012, 108 : 187 - 193
  • [44] Comparison of middle aged and older cancer survivors in the US Health and Retirement Study (HRS) and the Surveillance, Epidemiology, and End Results (SEER)
    Zhu, Peiyao
    Kobayashi, Lindsay C.
    Westrick, Ashly C.
    CANCER CAUSES & CONTROL, 2025,
  • [45] Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute
    Johnson, Derek R.
    Brown, Paul D.
    Galanis, Evanthia
    Hammack, Julie E.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 108 (01) : 187 - 193
  • [46] Rural representation of the surveillance, epidemiology, and end results database
    Herb, Joshua
    Wolff, Rachael
    McDaniel, Philip
    Holmes, Mark
    Lund, Jennifer
    Stitzenberg, Karyn
    CANCER CAUSES & CONTROL, 2021, 32 (03) : 211 - 220
  • [47] Prognostic Factors of Liver Transplantation for Hepatocellular Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis
    Li, Jun-bo
    Zhao, Yuan-yuan
    Dai, Chen
    Chen, Dong
    Wei, Lai
    Yang, Bo
    Chen, Zhi-shui
    CURRENT MEDICAL SCIENCE, 2023, 43 (02) : 329 - 335
  • [48] Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data
    Jagsi, Reshma
    Abrahamse, Paul
    Hawley, Sarah T.
    Graff, John J.
    Hamilton, Ann S.
    Katz, Steven J.
    CANCER, 2012, 118 (02) : 333 - 341
  • [49] Impact of marital status on survival of gastric adenocarcinoma patients: Results from the Surveillance Epidemiology and End Results (SEER) Database
    Qiu, Miaozhen
    Yang, Dajun
    Xu, Ruihua
    SCIENTIFIC REPORTS, 2016, 6
  • [50] Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
    Mirabello, Lisa
    Troisi, Rebecca J.
    Savage, Sharon A.
    CANCER, 2009, 115 (07) : 1531 - 1543